Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients

Published:2013-04-25 Issue:1 Volume:16 Page:91-95
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Atasoy B. M.,Dane F.,Alsan Cetin I.,Ozgen Z.,Ucuncu Kefeli A.,Ibrahimov R.,Turhal N. S.,Abacioglu U.,Turkeri L.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-013-1047-8.pdf

Reference19 articles.

1. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1.054 patients. J Clin Oncol. 2001;19:666–75.

2. Kaufman DS, Winter KA, Shipley WU, Heney NM, Chetner MP, Souhami L, et al. The initial results in muscle-invading bladder cancer of RTOG 95–06: phase I/II trial of transurethral surgery plus radiation therapy by selective bladder preservation or cystectomy depending on the initial response. Oncologist. 2000;5:471–6.

3. Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: ınitial results of Radiation Therapy Oncology Group 89–03. J Clin Oncol. 1998;16:3576–83.

4. Tester W, Caplan R, Heaney J, Venner P, Whittington R, Byhardt R, et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: Results of Radiation Oncology Group phase II trial 88–02. J Clin Oncol. 1996;14:119–26.

5. Tester W, Porter A, Asbell S, Coughlin C, Haeney J, Krall J, et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85–12. Int J Radiat Oncol Biol Phys. 1993;25:783–90.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer;Bladder Cancer;2023-06-27

2. BLADDER PRESERVATION WITH IMAGE-GUIDED RADIOTHERAPY FOR ELDERLY PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER: A SINGLE INSTUTION EXPERIENCE;The Turkish Journal of Geriatrics;2021-06-30

3. Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer;Canadian Urological Association Journal;2017-02-20

4. Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2016-06

5. Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma;Current Opinion in Urology;2015-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3